ZJYL — Jin Medical International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Annual income statement for Jin Medical International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16.2	20.8	19.2	19.8	23.5
Cost of Revenue
Gross Profit	5.5	6.36	6.2	6.78	9.5
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	13.8	18.1	17.1	17	19.9
Operating Profit	2.35	2.63	2.13	2.87	3.64
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2.35	2.88	2.74	3.22	4.18
Provision for Income Taxes
Net Income After Taxes	2.21	2.63	2.71	2.88	3.42
Minority Interest
Net Income Before Extraordinary Items
Net Income	2.21	2.63	2.71	2.88	3.68
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2.21	2.63	2.71	2.88	3.68
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.014	0.016	0.017	0.02	0.023
Dividends per Share